ArticleFrontiers in oncology2022

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients.

Hongying You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.